Know Cancer

or
forgot password

The Impact of Secondary Lymphedema After Head and Neck Cancer Treatment on Symptoms, Functional Status, and Quality of Life


Phase 1
18 Years
N/A
Not Enrolling
Both
Cancer Survivor, Head and Neck Cancer, Lymphedema

Thank you

Trial Information

The Impact of Secondary Lymphedema After Head and Neck Cancer Treatment on Symptoms, Functional Status, and Quality of Life


OBJECTIVES:

- To examine the association of secondary lymphedema, symptoms, functional status, and
quality of life after treatment in patients with head and neck cancer.

- To examine the possible factors contributing to the development of secondary lymphedema
in these patients.

OUTLINE: Participants undergo a physical and external (e.g., submental area) and internal
(e.g., larynx, pharynx, and oral cavity) lymphedema examination. Demographics, background,
and lymphedema treatment information are also collected. Participants' medical records with
head and neck cancer information and treatment are reviewed.

Participants complete surveys on Vanderbilt Head and Neck Symptom (VHNSS), Lymphedema
Symptom Intensity and Distress Survey Head and Neck (LSIDS-HN), Functional Assessment Cancer
Therapy-Head Neck (FACT-HN), Quality of Life Scale, Hospital Anxiety and Depression Scale
(HADS), and Body Image Scale.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Diagnosed with head and neck cancer

- At least 3 months since completion of head and neck cancer treatment

- Participating in the Pain and Symptom Management Program at the Vanderbilt-Ingram
Cancer Center

- No current evidence of cancer

- No metastatic disease

PATIENT CHARACTERISTICS:

- No other active cancer

- Able to understand informed consent

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- No concurrent chemotherapy or radiotherapy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Cross-Sectional

Outcome Measure:

Association between the severity of lymphedema with symptoms, functional status, and quality of life

Outcome Time Frame:

Cross-sectional

Safety Issue:

No

Principal Investigator

Jie Deng, RN, BSN, MSN

Investigator Role:

Principal Investigator

Investigator Affiliation:

Vanderbilt-Ingram Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

CDR0000669342

NCT ID:

NCT01098669

Start Date:

December 2009

Completion Date:

February 2012

Related Keywords:

  • Cancer Survivor
  • Head and Neck Cancer
  • Lymphedema
  • cancer survivor
  • lymphedema
  • head and neck cancer
  • Head and Neck Neoplasms
  • Lymphedema

Name

Location

Vanderbilt-Ingram Cancer Center Nashville, Tennessee  37232-6838
Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee  37064